This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Gynaecological Cancers
  • /
  • Bevacizumab Added to Moderate-dose Chemotherapy fo...

Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine Cancer.

Read time: 1 mins
Published:1st Jan 2018
Author: Bruckner HW, Gurell D, Hirschfeld A.
Availability: Pay for access, or by subscription
Ref.:Anticancer Res. 2018 Jan;38(1):547-552.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest